Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
- PMID: 25924912
- PMCID: PMC4415229
- DOI: 10.1186/s12883-015-0315-3
Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
Abstract
Background: One of the usual problems psychologists and clinicians face in clinical practice is differential diagnostics of Alzheimer's disease and depression. It has been reported that the ACE and ACE-R could discriminate the cognitive dysfunctions due to depression from that due to dementia, although this is not uniform in all studies. The current study aimed to evaluate the utility of the ACE-R to differentiate late-life onset depression (with severe episode) from mild-moderate Alzheimer's Disease (AD).
Methods: This study received approval from the Lithuanian Bioethics Committee. All participants were older than 50 years (mean age = 66.52 (±8.76) years). The study sample consisted of 295 individuals: 117 with severe depression, 85 with mild-moderate Alzheimer's disease (AD), and 94 age, gender and education matched participants of control group.
Results: The ACE-R had high sensitivity (100%) and specificity (81%) at detecting cognitive impairments related to AD. Patients with late-life onset depression (ACE-R mean 76.82, SD = 7.36) performed worse than controls (ACE-R mean 85.08, SD = 7.2), but better than the AD group (ACE-R mean 54.74, SD = 12.19). Participants with late-life onset depression were differentiated by mild impairment in the ACE-R total score with mild memory (13.79, SD = 6.29) and greater deficits in letter fluency (3.65, SD = 1.21) than in semantic fluency (4.68, SD = 1.23). Participants with AD were differentiated by severely impaired performance on attention and orientation (11.80, SD = 2.93), memory (8.25, SD = 3.47) and language subtests (17.21, SD = 4.04), and moderately impaired performance on verbal fluency (6.07, SD = 2.74).
Conclusions: ACE-R has diagnostic accuracy in detecting people with AD and can be used in differential diagnostics of late-life onset depression (severe episode) and AD. Diagnostic accuracy may be improved by analyzing the neuropsychological profiles and using lower cutoffs for different age groups.
Figures
Similar articles
-
Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.Dement Geriatr Cogn Disord. 2010;29(5):448-56. doi: 10.1159/000312685. Epub 2010 May 26. Dement Geriatr Cogn Disord. 2010. PMID: 20502019
-
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].Encephale. 2003 May-Jun;29(3 Pt 1):266-72. Encephale. 2003. PMID: 12876552 French.
-
Brazilian Version of Addenbrooke's Cognitive Examination-Revised in the Differential Diagnosis of Alzheimer'S Disease and Behavioral Variant Frontotemporal Dementia.Arch Clin Neuropsychol. 2022 Feb 23;37(2):437-448. doi: 10.1093/arclin/acab071. Arch Clin Neuropsychol. 2022. PMID: 34530438
-
A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia.Int Psychogeriatr. 2014 Apr;26(4):555-63. doi: 10.1017/S1041610213002329. Epub 2014 Jan 15. Int Psychogeriatr. 2014. PMID: 24423470 Review.
-
[Late life depression or prodromal Alzheimer's disease: Which tools for the differential diagnosis?].Encephale. 2018 Feb;44(1):52-58. doi: 10.1016/j.encep.2017.03.002. Epub 2017 Apr 20. Encephale. 2018. PMID: 28434642 Review. French.
Cited by
-
Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.Int J Clin Exp Pathol. 2015 Nov 1;8(11):13864-70. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823699 Free PMC article.
-
Cognitive Deficits in Late-Life Depression: From Symptoms and Assessment to Therapeutics.Focus (Am Psychiatr Publ). 2025 Apr;23(2):183-194. doi: 10.1176/appi.focus.20240046. Epub 2025 Apr 15. Focus (Am Psychiatr Publ). 2025. PMID: 40235602 Review.
-
The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease.Int J Geriatr Psychiatry. 2021 Jun;36(6):831-838. doi: 10.1002/gps.5483. Epub 2020 Dec 14. Int J Geriatr Psychiatry. 2021. PMID: 33275793 Free PMC article.
-
Differential Diagnosis Findings Between Alzheimer's Disease and Major Depressive Disorder: A Review.Psychiatry Clin Psychopharmacol. 2022 Mar 1;32(1):80-88. doi: 10.5152/pcp.2022.21133. eCollection 2022 Mar. Psychiatry Clin Psychopharmacol. 2022. PMID: 38764905 Free PMC article.
-
The role of semantic assessment in the differential diagnosis between late-life depression and Alzheimer's disease or amnestic mild cognitive impairment: systematic review and meta-analysis.Eur J Ageing. 2023 Aug 10;20(1):34. doi: 10.1007/s10433-023-00780-z. Eur J Ageing. 2023. PMID: 37563432 Free PMC article. Review.
References
-
- DesRosiers G. Primary or depressive dementia: hedonic tone and memory. Ph.D. dissertation, University of Cambridge, Cambridge, UK, 1994.
-
- Leplaire J, Buntinx G. The link between depression and dementia in the elderly. Clin Geriatrics. 1999;15:82–7.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous